ALFA FinderNSE filing, NSE: PRAMODINI. Summary written from the filing by ALFA Finder's alert engine.
Pramodini Medicare Ltd: key numbers
- Share price
- ₹107.45
- Market cap
- ₹236.9 Cr
- Revenue (annual)
- ₹62.29 Cr
- Net profit (annual)
- ₹17.38 Cr
- P/E (TTM)
- 13.6×Sector 75.2×
- Promoter holding
- 62.64%
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pramodini Medicare Ltd
All →Pramodini Medicare Board Meeting Date
Pramodini Medicare Limited intimated a board meeting on 13 November 2026 to consider half-year unaudited standalone and consolidated results. The trading window is closed from 1 October to 16 November 2026.
Pramodini Medicare Management Change
Pramodini Medicare Limited has appointed Mr. Rushikesh Vijay Gosavi as Company Secretary and Compliance Officer, effective 01st November 2025 and 21st March 2026 respectively.
Pramodini Medicare Merger & Restructuring
Pramodini Medicare Limited incorporated a new subsidiary, Sidheart Advanced Healthcare Private Limited, to operate a cardiac facility in Kodagu, Karnataka.
Pramodini Medicare Merger & Restructuring Worth ₹0.03 Cr
Pramodini Medicare Ltd incorporated a new subsidiary, Sidheart Advanced Healthcare Private Ltd, to operate a cardiac facility. The company acquired a 30% stake in the entity.
- Value
- ₹0.03 Cr
Pramodini Medicare Board Meeting Outcome
Pramodini Medicare's board approved forming the SPV Sidheart Advanced Healthcare, buying a Neosoft CT scanner, and appointing an internal auditor. No financial figures were disclosed.
Other other announcement announcements
All →Capricorn Systems Global Solutions Other Announcement
Capricorn Systems reports rights issue proceeds fully utilised as of September 30, 2026, with no deviation. This is a routine Regulation 32 utilisation statement.
Thrive Future Habitats Other Announcement
Thrive Future Habitats Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Note 1 records 93,12,364 shares allotted on warrant conversion, pending demat and lock-in.
Shelter Pharma Other Announcement
Shelter Pharma reports no deviation in use of Rs 2602.50 lakh warrant proceeds. The statement is certified by Alvi & Associates.
Thyrocare Technologies Other Announcement
Designated person Rahul Guha bought 2,121 Thyrocare shares via market purchase on November 6, 2026, worth ₹0.10 Crore. Post-trade holding is 200,859 shares.
- Value
- ₹0.10 Cr
Aavas Financiers Other Announcement
AAVAS Financiers disclosed that Morningstar Sustainalytics improved its ESG risk score to 21.4 from 23.9. The rating was assigned voluntarily without company engagement.
Brijlaxmi Leasing & Finance Other Announcement
Brijlaxmi Leasing claims exemption from related party transaction disclosure under Regulation 23(9) for FY2025-26. Its capital and net worth fall within Regulation 15(2) limits.